QTX3046

· Quanta Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QTX3046, covering 2025-07-25 to 2025-07-25. Get the full timeline:

Most recent: Clinical Trial Update: QTX3046 in Patients With KRAS G12D Mutations [Phase 1]